Bio-Rad Laboratories, Inc. today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin, secukinumab and the secukinumab–interleukin 17A drug-target complex.

Centauri Therapeutics Limited has announced three senior appointments: Dr. Jennifer Schneider as CEO, Dr. Helen Bright as vice president of research & development and Professor David Roblin FRCP FMedSci as chair of the board of directors.

Seegene Inc. has obtained EU approval for its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay that is compatible with the company’s fully automated AIOS.

Seegene Inc. has developed a PCR test to detect the monkeypox virus.

On Friday 1 July, Health Data Research UK launches its Health Data Science Black Internship Programme for 2022 helping to tackle the underrepresentation of Black people within science, technology, engineering, and mathematics careers. 

AMSBIO has expanded its range of antibodies, biomarkers and assay kits related to free radicals, non-radical reactive derivatives and antioxidants for researchers investigating the mechanism of oxidative stress.

Porvair Sciences announce eGecko² – an automated barcode application system that provides the ideal high throughput solution for precisely applying barcode labels onto racks of plates and Petri dishes.

Thermo Scientific EliA RNA Pol III and EliA Rib-P tests have been cleared by the U.S. Food & Drug Administration for aiding in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus.

Lonza has launched the PyroCell® Monocyte Activation Test - Human Serum System (PyroCell® MAT HS System), which uses human serum instead of fetal bovine serum.

ProteoGenix, Aseem Healthcare and Trident Biopharm Solutions are pleased to announce the development of a new antibody cocktail effective against major variants of SARS-CoV-2.